St. Jude wins European OK for brain implant to treat Dystonia
April 10 (Reuters) - St. Jude Medical Inc on Wednesday said it received European regulatory approval for its brain implant used to treat primary and secondary Dystonia, a neurological movement disorder.
The maker of heart pacemakers, valves and other medical devices said European regulators approved its Brio, Kibra and LibraXP deep brain stimulation systems for managing symptoms of the incurable disease.
Dystonia causes a person's muscles to involuntarily contract and spasm, and can leave its victims wheelchair-bound.
- Police seek motive in fatal Washington state school shooting
- Wall St. finally turning on Amazon as Bezos magic fades
- Two deputies killed, two others hurt in California shooting spree
- Easter Island's ancient inhabitants weren't so lonely after all
- Medical worker quarantined in New Jersey under new Ebola safeguards |